Join the Comirnaty group to help and get support from people like you.
Comirnaty News
AAP Issues New Vaccine Guidelines That Differ From U.S. Government Advice
WEDNESDAY, Aug. 20, 2025 — For the first time in 30 years, the American Academy of Pediatrics (AAP) has issued vaccine recommendations that differ from U.S. government guidelines. In new guidance r...
RFK Jr. Cancels $500M in mRNA Vaccine Research Projects
THURSDAY, Aug. 7, 2025 — U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has canceled nearly $500 million in grants and contracts meant to support mRNA vaccine d...
COVID-19 mRNA Vaccine Targeting Omicron JN.1 Lineage Safe
WEDNESDAY, Aug. 6, 2025 – Vaccination with the updated COVID-19 mRNA vaccine containing the severe acute respiratory syndrome coronavirus-2 Omicron JN.1 lineage was not associated with an increased...
Study Estimates COVID-19 Vaccinations Prevented More Than 2.5 Million Deaths in 2020 to 2024
MONDAY, Aug. 4, 2025 – COVID-19 vaccination during 2020 to 2024 was beneficial, but estimates are more conservative than previous calculations that focused on the first year of vaccinations,...
COVID-19 Vaccine Boosters Aid Outcomes in Patients With Cancer
TUESDAY, July 29, 2025 – COVID-19 vaccination boosters protect people with cancer developing from severe COVID-19, according to a study published online July 17 in JAMA Oncology. Jacek Skarbinski, ...
COVID Vaccines Saved More Than 2.5 Million Lives, Mostly Seniors
MONDAY, July 28, 2025 — More than 2.5 million deaths were prevented worldwide by the cutting-edge vaccines developed for COVID-19, mainly among seniors, a new analysis says. Essentially, one death w...
CDC Says COVID-19 Cases Rising in 25 States
MONDAY, July 14, 2025 — COVID-19 cases are on the rise again across the United States, with the biggest increases in parts of the South, Southeast and West Coast. The U.S. Centers for Disease Control ...
FDA Medwatch Alert: FDA Approves Required Updated Warning in Labeling of mRNA COVID-19 Vaccines Regarding Myocarditis and Pericarditis Following Vaccination
FDA Safety Communication June 25, 2025 Purpose: To inform the public and healthcare providers that FDA has required and approved updates to the Prescribing Information for Comirnaty (COVID-19 Va...
COVID Vaccine Protects Against Kidney Damage During Infection
MONDAY, June 16, 2025 — Kidney damage is common during a severe case of COVID-19, but vaccination appears to protect people against this life-threatening side effect, a new study says. Unvaccinated C...
RFK Jr. Ends COVID Vaccine Urging for Healthy Kids, Pregnant Women
WEDNESDAY, May 28, 2025 — The top U.S. health agency will no longer recommend the COVID-19 vaccine for healthy children and pregnant women. Tuesday's announcement by U.S. Health and Human Services S...
FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines
THURSDAY, May 22, 2025 — The U.S. Food and Drug Administration (FDA) has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines. The updated warnings highlight a rare risk of h...
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
NEW YORK & MAINZ, Germany--(BUSINESS WIRE) August 22, 2024 – Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the U.S. Food and Drug Administration (“...
Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine
This season’s vaccine is tailored to the SARS-CoV-2 XBB.1.5 sublineage and indicated as a single dose for most individuals 5 years of age and older Pre-clinical data show that the updated COVID-19 v...
Pfizer and BioNTech Announce U.S. FDA Approval of Their COVID-19 Vaccine Comirnaty for Adolescents 12 Through 15 Years of Age
Comirnaty® is the first and only COVID-19 vaccine to be granted FDA approval for adolescents 12 years and older, following emergency use authorization in May 2021 Approval of the two-dose primary ...
FDA Approves Comirnaty (Pfizer-BioNTech COVID-19 Vaccine) to Prevent COVID-19 Individuals 16 Years and Older
Comirnaty is the first COVID-19 vaccine to be granted FDA approval Approval is based on a comprehensive submission package including six-month efficacy and safety data after second dose More than...